Archives: Speakers

His industrial experiences commenced in 1984, which saw him working in various roles in the processing and food sectors. He originally joined Cama in 1990 in his present role as the county manager in France, with a focus on business development. Having left the company in 2000, he re-joined in 2017 and, following the departure of his predecessor, was once again offered the role of country manager. Therville heads a very dedicated French team, comprising mechanical and software service engineers, sales operatives, sales-support personnel and office-support staff

Sophie is Product Development Director for Givaudan Taste & Wellbeing in Europe where she works with her team to define, test and commercialize innovations from the Givaudan food & beverage portfolio for European high growth platforms. She was previously Innovation Director for Sweet Goods & Dairy for Europe, Africa and the Middle East at Givaudan and also spent 12 years at Givaudan leading teams driving commercialization of sensory and consumer relevant innovation. Sophie has worked for Kraft Foods, Bel Group and HJ Heinz in various roles in the domain of sensory science and consumer insights. She graduated from the Institut National Supérieur de Formation Agro-alimentaire with a master’s degree in Food Science.

Amer is currently the Managing Director of GxP Compliance and Training Partners (GCTP) founded to help pharmaceutical companies & academic institutions worldwide to achieve compliance with GCP, GVP, GCLP, GDP and GLP. A clinical pharmacologist by education, he is a senior executive with 28 years’ experience within pre-clinical, clinical R&D and pharmacovigilance (PV) operations helping biotech and pharmaceutical companies worldwide to achieve compliance with GxPs (Good Laboratory Practice (GLP), Good Clinical Practice (GCP), Good Clinical Laboratory Practice (GCLP), Good Vigilance Practice (GVP) and Good Distribution Practice (GDP)) Quality Assurance (QA). Amer enjoys imparting his experiences through training provision and has, for over 25 years, been delivering training on GxP QA, clinical development/operations and Pharmacovigilance, as well as being an invited speaker at over 130 international congresses and as writer, published 2 reference books, The Pharmaceutical Medicine Dictionary and The Dictionary of Pharmacovigilance and other publications. Earlier in his career, he was Assistant Editor for 11 medical journals and was the first invited Course Director for The Pharmacovigilance Auditing Course at the RQA. Amer has over 21 years’ experience of directing and hosting Inspection Readiness Programs (Mock Inspections and Pre- / Post-Mock Inspection-Training). His other previous positions include: Vice President GxP Quality Assurance, Compliance & Training at Karyopharm Therapeutics Inc. USA, Global Director, Head of Quality Assurance at Merck Serono, Switzerland, Global Head of GxP Quality Assurance at Arpida Ag., Switzerland, Senior International Clinical Quality Assurance Audit Manager at Novartis Headquarters, Switzerland and he was the first Pharmacovigilance Compliance Officer of the MHRA where he conducted the first GCP-GVP inspection in the EU.

Jessica Cordes studied Molecular Life Science in Luebeck and started her business career for 2 years at the Central Lab MDS Pharma Services as project manager.

She moved then to GlaxoSmithKline where she worked as country project leader for 4 years.

In 2013, she moved to MorphoSys, working in an international role as clinical trial leader overseeing clinical trials with antibodies.

2017 she moved to Medigene as clinical trial manager, planning and implementing a cell therapy clinical trial and in 2018 took over the leadership for Clinical Operations while building the group. In 2021, she joined Immatics being responsible for building a global cohesive Clinical Operations department and leading the operational strategy for the global conduct of all clinical trials.

Dr. Nitsan Halevy is the Chief Medical Officer at Pluristem Therapeutics, where she leads clinical and regulatory activities. Nitsan has over 15 years of experience leading global clinical research and drug development programs. From an academic setting at Brigham and Women’s Hospital (Boston), Nitsan transitioned to industry, where she has held roles of increasing responsibility and scope at Novartis, Teva and Quark Pharmaceuticals. She holds an MD from Ben-Gurion University.